TITANIC-XV Trial: Prospective, Multicenter and Randomized Trial (Bioactive Bare Metal Titanium Stent Versus Everolimus Drug Eluting Stent).
Phase of Trial: Phase III
Latest Information Update: 13 Jan 2012
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Diabetic angiopathies
- Focus Therapeutic Use
- Acronyms TITANIC-XV
- 13 Jan 2012 Additional trial location (Finland) and actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.
- 13 Jan 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 11 Nov 2011 Results presented at the 23rd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.